KALV Market Structure

KalVista Pharmaceuticals, Inc. (KALV) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1.44B, listed on NASDAQ, employing roughly 275 people, carrying a beta of -0.29 to the broader market. KalVista Pharmaceuticals, Inc. Led by Benjamin L. Palleiko, public since 2015-04-09.

Market structure data reveals where a stock trades across exchanges, dark pools, and alternative trading systems. Understanding off-exchange activity helps identify institutional trading patterns and liquidity dynamics.

Latest Week Ending

2026-06-08

Weekly OTC Shares

470.5K

Weekly OTC Trades

1.2K

12-Week Total Shares

66.6M

Avg Trade Size (12-Week)

1.4K shares

How Single-Name Off-Exchange Volume Affects Options

For single-name equities, persistent off-exchange volume concentrations can flag institutional positioning - large blocks arranged through ATS venues to avoid lit-market impact, or correlation-arbitrage flow from sector rotation. The flow doesn't directly move the lit-market price (it prints at the ATS) but it changes the inventory position of the institutional counterparty, which then drives subsequent lit-market flow. Compare the off-exchange volume series above with KALV's gamma exposure and options volume history to see whether unusual dark-pool activity coincides with rebalancing in the options book.

Showing 12 weeks of off-exchange trading data for KalVista Pharmaceuticals, Inc..

Learn how market structure is reported and how to read the data →